Back to Gene
CDKL5 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

CDKL5 gene

The CDKL5 gene provides instructions for a protein essential for normal brain development, nerve cell function, and synaptic signaling.

Normal Function

The CDKL5 gene provides instructions for making a protein that is most active in the brain. The CDKL5 protein acts as a kinase, an enzyme that modifies the activity of other proteins by adding a phosphate group to them. It is involved in the formation, growth, and migration of nerve cells (neurons) and the transmission of chemical signals at the connections between neurons (synapses). It may target the MeCP2 protein, which is also critical for neuronal function.

Health Conditions Related to Genetic Changes

CDKL5 deficiency disorder

At least 150 mutations in the CDKL5 gene cause CDKL5 deficiency disorder, a rare condition characterized by:

  • Seizures beginning in infancy
  • Significant developmental delays
  • Severe intellectual disability
  • Inability to walk independently

About 90 percent of those diagnosed are female. While previously classified as an atypical form of Rett syndrome, it is now considered a separate condition. Mutations in the CDKL5 gene reduce the amount of functional protein or alter its activity in neurons. Mutations in the kinase domain—the region essential for the protein's function—are associated with more severe signs and symptoms compared to mutations in other regions of the protein.

Other Names for This Gene

  • CDKL5_HUMAN
  • CFAP247
  • cyclin-dependent kinase-like 5
  • serine/threonine kinase 9
  • STK9

Frequently Asked Questions

Look for seizures that start within the first few months of life, especially if they are frequent, hard to control, or accompanied by poor eye contact, limited smiling, and delayed motor milestones such as rolling over or sitting. If these signs appear together, discuss genetic testing with a pediatric neurologist.
Most individuals have severe motor impairment and do not walk independently. Speech is usually absent, but many develop purposeful hand use and can communicate with augmentative devices (eye‑tracking or picture boards). Early intensive therapy (physical, occupational, speech) can improve functional abilities, but developmental progress remains limited.
clinical diagnostic lab performs sequencing of the CDKL5 gene from a blood sample (or occasionally saliva). Both single‑nucleotide changes and larger deletions/duplications are assessed, and results are interpreted by a medical geneticist.
Seizure control is challenging; many patients benefit from a combination of antiepileptic drugs (e.g., vigabatrin, topiramate, or clobazam) and, in refractory cases, a ketogenic diet or vagus‑nerve stimulation. Newer therapies such as cannabidiol (CBD) oil are being studied, but response varies, so treatment must be individualized.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab